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Abstract 
Introduction 
Neovascularization contributes to the development of sustained synovial inflammation in the 
early stages of Rheumatoid Arthritis. Ultrasound (US) provides an indirect method of 
assessing synovial blood flow and has been shown to correlate with clinical disease activity 
in patients with Rheumatoid Arthritis. This study examines the relationship of US determined 
synovitis with synovial vascularity, angiogenic / lymphangiogenic factors and cellular 
mediators of inflammation in a cohort of patients with early Rheumatoid Arthritis (RA) 
patients prior to therapeutic intervention with disease modifying therapy or corticosteroids. 
Methods 
An ultrasound guided synovial biopsy of the supra-patella pouch was performed in 12 
patients with early RA prior to treatment. Clinical, US and biochemical assessments were 
undertaken prior to the procedure. Ultrasound images and histological samples were obtained 
from the supra-patella pouch. Histological samples were stained for Factor VIII and a-SMA 
(a-smooth muscle actin). Using digital imaging analysis a vascular area score was recorded. 
QT-PCR (quantitative-PCR) of samples provided quantification of angiogenic and 
lymphangiogenic gene expression and immunohistochemistry stained tissue was scored for 
macrophage, T cell and B cell infiltration using an existing semi-quantitative score. 
Results 
Power Doppler showed a good correlation with histological vascular area (Spearman r - 0.73) 
and angiogenic factors such as vascular endothelial growth factor- A (VEGF-A), 
Angiopoietin 2 and Tie-2. In addition, lymphangiogenic factors such as VEGF-C and VEGF-
R3 correlated well with US assessment of synovitis. A significant correlation was also found 
between power Doppler and synovial thickness, pro-inflammatory cytokines and sub-lining 
macrophage infiltrate. Within the supra-patella pouch there was no significant difference in 
US findings, gene expression or inflammatory cell infiltrate between any regions of 
synovium biopsied. 
Conclusion 
Ultrasound assessment of synovial tissue faithfully reflects synovial vascularity. Both grey 
scale and power Doppler synovitis in early RA patients correlate with a pro-angiogenic and 
lymphangiogenic gene expression profile. In early RA both grey scale and power Doppler 
synovitis are associated with a pro-inflammatory cellular and cytokine profile providing 
considerable validity in its use as an objective assessment of synovial inflammation in 
clinical practice. 
  
Introduction 
Neovascularization is defined as the development of new blood vessels from the existing 
microvascular bed. It involves a number of steps including endothelial cell division, selective 
degradation of vascular basement membranes, alteration of the surrounding extracellular 
matrix and endothelial cell migration [1,2]. Furthermore, variation in the expression of 
angiogenic regulators, such as VEGF and angiopoietin proteins, helps mediate this process 
and can be detected in synovial tissue [3-5]. Similarly, pro-inflammatory cytokines, such as 
TNF-α, IL-1 and IL-6, are though to have a direct influence on new vessel formation within 
the synovium via VEGF-dependent pathways [6]. Thus a concert of angiogenic factors is at 
work within the rheumatoid synovium to promote new vessel formation. This is an early, 
critical aspect to synovial pannus formation and facilitates the perpetuation of the 
inflammatory process within synovial joints [7]. In addition, lymphatic vessel formation 
(lymphangiogenesis) is also an important factor for normal tissue homeostasis and can be 
detected in rheumatoid synovial tissue. Lymphatic vascular networks have previously been 
described in both patients and animal models of arthritis with VEGF-C, and its ligand VEGF-
R3, appearing to promote sprouting of lymphatic vessels in a similar fashion to 
neoangiogenesis [8-10]. 
Ultrasound imaging of synovial joints provides an objective assessment of synovial 
hypertrophy, referred to as grey-scale synovitis, and vascular flow within the synovium, 
Power Doppler signal. Imaging of this network of new vessels within hypertrophied synovial 
tissue is purported to provide indirect evidence of tissue inflammation. Previous authors have 
correlated PDS and both macroscopic and microscopic synovial vascularity assessments [11-
15]. Most recently, Anderson et. al. demonstrated that Doppler colour fraction was 
association with immunohistochemical staining for von Willebrand factor [15]. However the 
relationship of US measures of synovitis and synovial tissue angiogenic factors, 
inflammatory cytokines and vessel density has not been previously explored. The aims of this 
study were to firstly, examine the variability of ultrasonographic measures of synovitis and 
synovial vascularity within the knee joint of patients with early Rheumatoid Arthritis. 
Secondly, examine the relationship of histological vascular density and Power Doppler signal 
assessment. Finally, using gene expression, correlate both synovial hypertrophy and Power 
Doppler signal with vascular mediators of angiogenesis, lymphangiogenesis and pro-
inflammatory cytokines. 
Methods 
Patients 
12 patients with early Rheumatoid Arthritis were recruited as part of an ongoing study in 
patients with early inflammatory arthritis. Disease duration was considered to be from 
reported symptom onset. All patients were recruited from the early arthritis clinic within the 
department of rheumatology, Barts Health NHS Trust. All patients had a clinically involved 
knee joint and fulfilled the ACR diagnostic criteria (1987) for Rheumatoid Arthritis. Patients 
were treatment naive prior to all assessment and received a clinical assessment; ultrasound 
examination and ultrasound guided synovial biopsy from the supra-patella pouch. All 
procedures were performed following written informed consent and were approved by Kings 
College hospital, London, ethics committee (REC 05/Q0703/198). 
Ultrasound guided synovial biopsy technique 
US guided synovial biopsy and standard US images were performed using a GE Logic 9 
ultrasound machine with a 2-dimensional M12L transducer as previously described [16]. 
Using a 14G Quick-Core® Biopsy Needle (Cook medical, Limerick, Ireland), tissue was 
harvested from the medial, middle and lateral aspects of the supra-patella pouch. The needle 
biopsy was repeatedly positioned in each of the three segments and the ultrasound probe used 
to guide the throw of the needle into the correct anatomical position. A minimum of 6 
samples were retrieved form each region of interest (typically 6–10 samples). Samples were 
retrieved from each region and separately processed for immunohistochemistry and RNA 
extraction. 
Ultrasound score 
Ultrasound images of the knee and supra-patella pouch (SPP) were recorded by a single 
operator (MD) and analyzed by two independent examiners (SK, NN) blinded to the clinical 
and histological data. Three standardized, 3 second cine loops, were recorded pre-biopsy 
from i) the midline SPP pouch ii) medial SPP pouch iii) lateral SPP pouch corresponding to 
region of synovial tissue sampling with the knee in 30 degrees of flexion. A single 
sonographer acquired all images. The area demonstrating the maximum Doppler and synovial 
thickness, within each third of the suprapatella pouch, was selected. Training was provided 
along side an atlas of probe positions to guide image acquisition. The superior border of the 
patella was visualized prior to image acquisition. The medial corner of the upper border of 
the patella corresponding to the base of the medial US image and the lateral corner similarly 
corresponding to the base of the lateral US image. The midline image included the quadriceps 
tendon as it inserts into the patella with visualization of the pre-patella fat pad lying superior 
to the suprapatella pouch. Synovial tissue was defined as hypoechoic non-compressible intra-
articular tissue. Power Doppler settings were adjusted to the lowest permissible pulse 
repetition frequency to maximize sensitivity. Maximum colour gain was used without 
creating artifactual noise. A standard depth of 3.8 cm was used for each image acquisition. 
Quantitate analysis of the recorded cine loops were performed using Image J (NIH, [17]. 
1997–2008) non-proprietary freeware. A dedicated macro was used. The use of a cine loop 
allows selection of the maximal Doppler signal in that particular region of interest given the 
variations with blood flow with cardiac output. The software facilitates manual drawing of 
the outline of the synovium within the supra-patellar pouch. Care was taken to isolate 
synovial fluid from the region of interest. The output of the software provides information on 
the image selected and corresponding pixel count for both synovial area and Doppler signal. 
Quantitative measurements provided included synovial area quantitative score (SQuant) and 
power Doppler area quantitative score (PQuant), high intensity power Doppler signal 
(representing high velocity blood flow) over a predetermined colour threshold (PDHi) and a 
ratio of synovial to Doppler area (PQuant/SQuant). A qualitative score was applied to both 
the grey scale synovial thickness (SSS - Synovial Semi-quantitative Score) and total power 
Doppler vascular signal, (PSS - Power Doppler Semi-quantitative Score) for each region of 
the SPP on a 0–3 ordinal scale. Images were scored quantitatively and qualitatively by two 
experienced readers (NN and SK) with good agreement (Grey scale synovial thickness - ICC 
0.87, Power Doppler ICC 0.96). 
Synovial tissue processing 
Each synovial specimen was divided into two parts: one was formalin fixed and paraffin 
embedded for immunohistologic analysis and the second was stored in RNA later (AMBION) 
at −80 °C until RNA extraction and QT.PCR analysis. 
Immunohistochemistry 
Paraffin embedded tissue specimens were cut in consecutive 3 μm-thick sections. A 
haematoxylin and eosin stain was performed to ensure tissue morphology was preserved: 
only tissue sections with an intact lining layer were used and tissue was graded according to a 
previously reported scoring system (Krenn synovitis score) [18]. Immunohistochemistry 
stained specimens for T-cells, macrophages and plasma cells (CD3, CD68 & CD138 
respectively) are scored on a 5 point scale: 0–4 depending on the increasing number of 
positively stained cells calibrated against a standardised atlas [19]. 
To quantify vascular density in the synovial tissue in terms of both number and size of 
vessels profiles, a double immunofluorescent staining for factor VIII and α-SMA was used. 
The following primary antibodies were used for immunofluorescence analysis: mouse anti 
human factor VIII (clone F8/86; Dako, Glostrup, Denmark), Cy3 conjugated mouse anti α-
SMA (clone 1A4; Sigma, Missouri, USA). The appropriate secondary antibody for Factor 
VIII was obtained from Invitrogen, Paisley, UK. As negative control irrelevant isotype –
matched antibodies (Dako, Glostrup, Denmark) were used. Briefly, antigen retrieval was 
performed by heating for 35 minutes at 95 °C in Dako Target Retrieval Solution. Sections 
when then washed in Tris Buffered saline, incubated with protein block (Dako, Glostrup, 
Denmark) and then in the first primary antibody for one hour (mouse anti human factor-VIII 
using antibody dilution of 1:50). After washing, the appropriate Alexa-488 conjugated 
secondary antibody was applied for 30 minutes; sections were then washed and the directly 
conjugated second primary antibody, α-SMA, was added at dilution of 1:200. Synovial tissue 
was counterstained with 4’-6-diamidino-2-phenylindole (DAPI) and mounted with anti fade 
mounting medium. To obtain a more representative assessment of synovial vascularity all 
available synovial specimens were cut and stained at two different cutting levels, 50 μm 
apart. Sections without a defined synovial lining, or with folded areas after staining, were 
omitted from the analysis. Assessors of histological scores and vascular area assessments 
were blinded to patient characteristics and ultrasound findings. 
Digital image analysis for synovial vascularity evaluation 
One observer blinded to patients and clinical data, performed both image acquisition and 
subsequent image analysis for all the sections. Digital images of immunofluorescent stained 
synovial blood vessels, were acquired at 20X magnification on a fully automated Olympus 
BX61 microscope, captured using a video camera and then digitized using Cell P image 
analysis software. Each acquisition was performed in one single session for each vascular 
marker, factor-VIII and α-SMA, respectively, with fixed variable as derived from the 
calibration. The obtained factor-VIII and α-SMA stained images were saved in jpeg format 
and used for the subsequent digital images analysis. A selected area was defined as the region 
of interest (ROI) for both blood vessel density evaluation and digital vessel size analysis. The 
vascular objects greater than 10 μm in diameter were quantified within the selected ROI, 
using Cell P analysis software and expressed as blood vessel numerical density (number of 
vessel per square millimeter - BV / mm
2
) and vessel fractional area (synovial vascular area - 
SVA / mm
2
) respectively (Figure 1A). Vessels were sub-catergorised using a unique colour 
based on blood vessel area (Figure 1B). Vascular density, cellular markers of inflammation 
and US parameters were assessed for each region within the SPP (Figure 1C). 
Figure 1 Synovial tissue stained with Factor VIII demonstrating vessels and gated 
digital analysis for different sized vessels. A: Digital image of immunofluorescent stained 
synovial blood vessels at 20X magnification (Olympus BX60 microscope). Synovial tissue 
with factor VIII staining indicating vessel wall fluorescence (pink). B: Division of vessel size 
using digital imaging analysis based on specified generated gates with colour differentiation. 
Blue / Green - large, Red - medium, Grey - small). C: Corresponding vascular histology 
stained with vWF, CD68 immunohistochemistry and knee power doppler images for the 
midline supra-patella pouch (SPP). VWF and CD68 staining at 10x magnification (Olympus 
BX60 microscope). US images from GE logiq 9 machine with 12 MHz probe. High, 
intermediate and low levels of vascularity and inflammation indicated. 
QT-PCR of endothelial specific genes 
Total RNA was extracted from the remaining portion of synovial tissue stored in RNA later, 
using the RNeasy Mini Kit (Qiagen, Chatsworth, CA)), with on column DNase I digestion to 
avoid genomic DNA contamination. Seven of the thirteen (7/13) patients had additional 
tissue available for RNA extraction. cDNA was generated from 1 ug of RNA using the 
Thermoscript RT-PCR System (Invitrogen, San Diego, CA). QT-PCR was performed to 
detect mRNA expression levels of Ang-1, Ang 2, VEGF-A, VEGF-C Tie-2 and VEGFR3. 
The RT-PCR was run in triplicate with an equal loading of 20 ng of cDNA/well. Results were 
analysed after 40 cycles of amplification using the ABI PRISM 7900HT Sequence Detection 
System Version 3. Relative quantification was measured using the Comparative Ct 
(Threshold Cycle) Method. cDNA from human placenta was used as a positive control. 
Statistics 
Statistical analysis was performed with SPSS version 16. Demographic characteristics of 
patients are described with mean and interquartile ranges. Correlations between variables 
were expressed by Spearmans rho test. Multiple linear regression was performed to analysis 
the relationship between ultrasound parameters and vascular area, immunohistochemistry and 
gene expression. P values <0.05 were taken as statistically significant. 
Results 
Patient demographics 
12 patients were biopsied (9 female, 3 male) with a mean age of 47 (IQ 37–57). All patients 
had symptoms of less than 12 months duration with an average of 7 months from symptom 
onset to recruitment. 5 patients (42%) were seropositive for Rheumatoid factor with 4 
patients (33%) being positive for anti-CCP antibodies at presentation. The median DAS28 
score was 5.41 (IQ 4.46-6.34), Table 1. 
  
Table 1 Patient demographics (n = 12) 
 N (%) 
Gender  
    - Female 9 (75) 
    - Male 3 (25) 
Age  
(years) median 47 (IQ 37–57) 
Disease duration  
(months) median 7.2 (IQ 4.9-9.5) 
Serology  
    - Rheumatoid factor 5 (41.6) 
    - Anti-CCP 4 (33.3) 
DAS28 (ESR) 5.41 (IQ 4.46-6.34) 
Inflammatory markers  
    - ESR 43 (IQ 31–55) 
    - CRP 23 (IQ 18–28) 
NSAID use 4 (33.3) 
All patients were recruited form an early arthritis clinic with symptom onset less than 1 year with a mean 
DAS28 score of 5.41. Disease duration taken from the onset of initial symptoms. 42% of patients were RF factor 
positive, 33% anti-CCP positive. A third of patients were receiving anti-inflammatory medication prior to 
recruitment. Numbers are reported with percentages otherwise mean and interquartile range are used where 
specified. RF - Rheumatoid Factor, CCP - cyclic citrullinated peptide, ESR - erythrocyte sedimentation rate, 
CRP - C-reactive protein, IR – Interquartile range, NSAID - Non-steroidal anti-inflammatory drug. 
Vascularity, gene expression and ultrasound parameters are stable within the 
supra-patella pouch 
The three areas of the supra-patella pouch were analyzed for angiogenic gene expression, 
vascular density and ultrasound parameters. Within the SPP there was no significant variation 
in TNF-α expression (Kruskal-Wallis; p = 0.31), (Figure 2A). There was no significant 
difference found in the gene expression profile for any other angiogenic / lymphangiogenic 
factors or pro-inflammatory cytokines examined. In addition, there was no significant 
difference in the vascular area measurement in each region, although there was a tendency for 
the lateral compartment to have slightly greater values than the medial and middle 
compartments (Figure 2B). No difference was detected in the ultrasound parameters within 
the SPP pouch although again, higher levels of PQuant and PSS were noted in the lateral 
compartment along with higher levels of SQuant and SSS (Figure 2C and D). The ratio of 
PQuant / SQuant remained stable throughout the three regions of interest with no significant 
difference detected between regions (Figure 2E). 
Figure 2 No significant variation of ultrasound, vascular area and gene expression 
between each region of the supra patella pouch (SPP). A: TNF alpha expression by by 
each region of interest within the SPP. (Kruskal-Wallis p = 0.31) B: PQuant (pixels) by each 
region of interest within the SPP. (Kruskal-Wallis p = 0.27) C: SQuant (pixels) by each 
region of interest within the SPP (Kruskal-Wallis p = 0.19) D: Synovial vascular area / mm2 
by by each region of interest within the SPP. (Kruskal-Wallis p = 0.09) E: PQuant/SQuant 
ratio by each region of interest within the SPP (Kruskal-Wallis p = 0.44). 
Grey scale and power Doppler synovitis correlate with angiogenic, 
lymphangiogenic gene expression and sub lining macrophage infiltrate 
Quantitative power Doppler assessment correlated well with TNF-α, IL-1β and IL-6 gene 
expression (Spearmans rho - 0.61, 0.69 and 0.59 respectfully). Good correlation was also 
demonstrated with angiogenic factors such as VEGF-A and VEGF-R3 (Figure 3A-D). 
Quantitative synovial thickness area correlated significantly with pro-inflammatory cytokine 
expression and angiogenic factors such as VEGF-A, Angiopoietin 2 and Tie 2 (Figure 3E-H). 
With respect to lymphangiogenesis, a significant correlation was confirmed with synovial 
thickness area and VEGF-R3, VEGF-C, and Podoplanin, a lymphatic endothelial marker 
(Spearmans rho – 0.61, 0.62 and 0.71 respectfully). A modest correlation was also 
demonstrated with CD68SL macrophage infiltration and quantitative ultrasound assessments 
(PQuant, SQuant, PDHi). Table 2 provides an overview of the correlation matrix of US 
parameters, angiogenic, lymphangiogenic factors and cellular mediators of inflammation. 
Figure 3 PQuant and SQuant correlate with angiogenic and lymphangiogenic factors. 
Graphical representation of PQuant and SQuant (measured in pixels) relationship with 
VEGFa, Angiopoietin 2, IL-1b and VEGF-R3. Regression line and 95% CI shown in each 
graph. A: PQuant correlated with VEGFa on the y - axis (Spearman r = 0.52). B: PQuant 
correlated with Angiopoietin 2, (Spearman r = 0.61). C: PQuant correlated with IL-1b, 
(Spearman r = 0.68). D: PQuant correlated with VEGF-R3, (Spearman r = 0.61). E: SQuant 
correlated with VEGFa on the y - axis (Spearman r = 0.56). F: SQuant correlated with 
Angiopoietin 2, (Spearman r = 0.74). C: SQuant correlated with IL-1b, (Spearman r = 0.81). 
D: SQuant correlated with VEGF-R3, (Spearman r = 0.61). 
Table 2 Correlation matrix of US parameters with angiogenic, lymphangiogenic 
cytokines expression and cellular infiltration 
US parameter PSS SQuant PQuant PDHi PQuant / SQuant 
TNF-alpha 0.46* 0.74* 0.61* 0.60* 0.59* 
IL-6 0.30 0.69* 0.59* 0.56* 0.57* 
IL-1 beta 0.47* 0.81* 0.68* 0.64* 0.67* 
Podoplanin 0.19 0.71* 0.43 0.15 0.32 
Angiopoietin 1 0.4 0.37 0.22 0.11 0.23 
Angiopoietin 2 0.5 0.74* 0.61* 0.46 0.56* 
VEGF-R3 0.50* 0.61* 0.55* 0.36 0.47 
VEGF-C 0.2 0.62* 0.39 0.14 0.29 
VEGF-A 0.5 0.56* 0.52* 0.48* 0.54* 
Tie-2 0.3 0.51* 0.44 0.19 0.34 
Synovitis score 0.25 0.18 0.27 0.48* 0.31 
CD68SL 0.29 0.35* 0.40* 0.51* 0.40* 
CD68L 0.12 0.46* 0.18 0.33 0.09 
CD20 0.02 0.24 0.25 0.38* 0.22 
All correlation's performed using Spearmans rho. Values marked * are significant with p <0.05. SQuant 
correlated with the majority of pro-inflammatory cytokines, angiogenic, lymphangiogenic gene expression and 
macrophage lining and sublining infiltration. PSS – Power Doppler semi-quantitative score, SQuant - 
quantitative synovial thickness area, PQuant - quantitative power Doppler area, PDHi - quantitative thresholded 
Power Doppler area, TNF - Tumor necrosis factor, IL - interleukin, VEGF - Vascular endothelial growth factor, 
Tie - Tyrosine kinase (predominant endothelia cell expression), CD68SL - macrophage marker (synovial sub-
lining layer), CD68L - macrophage marker (synovial lining layer). 
Synovial vascular area is a predictor of Power Doppler signal 
Quantitative and semi-quantitative US parameters were correlated with synovial vascular 
density and blood vessel number density. Quantitative power Doppler area correlated with 
synovial vascular area / mm
2
 and blood vessel no. / mm
2
 (Spearmans rho - 0.73 and 0.53 
respectfully) - Figure 4A & B. All US parameters positively correlated with both histological 
assessments of synovial vascularity except for blood vessel number / mm
2
 which did not 
correlate significantly with semi-quantitative PSS score. Linear regression shows a positive 
relationship between quantitative power Doppler area assessment and histological synovial 
vascular area / mm
2
 (r
2
 - 0.49). Division and analysis of the synovial vascular area by size of 
vessel demonstrated that medium sized vessels contributed most to the overall vascular area 
(79%) within each tissue specimen with small and large vessels contributing on 9.5% and 
11.5% respectively. A significant correlation between the high intensity Doppler signal 
(PDHi) and medium sized vessels overall area was demonstrated (Spearmans rho - 0.55) - 
Figure 4C. 
Figure 4 Synovial vascular predicts Doppler signal within the knee joint. A: Qualitative 
Doppler assessment (PQuant) correlates with synovial vascular density within the SPP 
(Spearman r - 0.73) B: PQuant correlates with blood vessel density (Spearman r - 0.42). C: 
Thresholded doppler signal for high intensity signal (PDHi) correlates with medium-sized 
vessel vascular area (Spearman r - 0.56). 
Discussion 
For patients with suspected inflammatory arthritis undergoing US examination, the detection 
of grey scale synovial thickening and power Doppler signal within synovial joints is an 
important aspect of the disease assessment. An appreciation of the ultrasonographic 
histopathological correlates is essential to the interpretation of these findings in the clinical 
setting. To minimize the influence of treatment effects in this patient population, patients 
naive to therapy (including corticosteroids and disease modifying drugs) were recruited. All 
had active rheumatoid disease with a moderate to high DAS 28 score prior to biopsy and a 
knee joint which was deemed clinically inflamed. 
In this study, histologically assessed synovial vascular area was an independent predictor of 
ultrasound assessment of power Doppler signal as assessed by PQuant and PDHi. Assessing 
the relationship of PQuant to synovial vascularity in this study differed from previous reports. 
Synovial vascularity has previously been assesses macroscopically, with 
immunohistochemistry staining of factor VIII and by a semi-quantitative ordinal scale [11-
13,15,20]. In this study we favored a quantitative approach to tissue assessment with the 
vascular area being scored using Digital Imaging Analysis. This has a number of advantages 
including scoring standardisation and providing a fractional vascular area assessment in 
addition to a measure of the vessel number and density. In addition to vascular density, a 
correlation was also detected between Power Doppler signal and pro-inflammatory cytokines 
(IL-1β and TNF-α). This may suggest that other factors exert influence over the generation of 
Doppler signal in addition to the available synovial vascular networks. It is likely that these 
vasoactive cytokines contribute by exerting a degree of control over the afferent vascular 
tone, modifying the local blood flow. The correlation of other angiogenic factors (such as 
VEGF-A, Tie2 and Ang 2, but not with Ang 1) with both synovial thickness and power 
Doppler, may indicate a profile of synovial tissue primed for neovascularisation. Up-
regulation of VEGF-A and Ang 2 in this context may be an important factor in 
neovascularization within the rheumatoid joint. Similarly, over expression of VEGF-A and 
Ang2 has a positive effect on tumour growth while over expression of Ang1 reduces tumor 
expansion [21,22]. We also demonstrate that expression of lymphangiogenic factors 
correlated with ultrasound parameters and in particular synovial area assessment. 
Lymphangiognesis is an important process in tissue development and regulation with VEGF-
C and its receptor VEGF-R3 known to be important factors in this process [8,23]. The 
association with the quantitative synovial area score may suggest that this is seen within an 
expanding, inflamed synovium. However, a report from Polzer et al. suggested that 
lymphangiogenesis was encouraged following treatment with anti-TNF alpha therapy with a 
greater expression of lymphatic vessels in synovial tissue when examining pre and post 
treatment synovial tissue [10]. The expression of VEGF-C and VEGF-R3 however were not 
specifically commented upon in this study. The angiogenic / lymphangiogenic profile data 
presented here, however, is cross-sectional limiting any conclusions regarding the regulation 
of these factors following treatment or any change in their relationship with US assessment. 
Histological parameters and angiogenic gene expression demonstrated variation within the 
suprapatella pouch. Furthermore, the US parameters did reveal a higher average signal in the 
lateral compartment of the joint. The small number of patients in this study, and subsequent 
limited gene expression data available in 7 out of 12 patients, means that a conclusion 
regarding the variation in gene expression, ultrasound parameters and histology through out 
the joint space is problematic. Whilst none of these comparisons reached statistical 
significance, the small number of patients within this study is likely to be underpowered to 
detect a real difference. 
Synovial hypertrophy, as assessed by US, consists of a number of cellular elements (resident 
and migratory), interstitial fluid, connective tissue and a vascular network. This study shows 
a positive correlation with both cellular elements such as CD68SL macrophages, pro-
inflammatory cytokines and both angiogenic and lymphangiogenic factors. This cocktail of 
cellular infiltration and cytokines promote an inflammatory environment responsible for 
many the changes taking placed within the joint. 
Conclusion 
In this study of patients with early Rheumatoid Arthritis, we demonstrate a clear relationship 
between power Doppler signal, histologically determined synovial vascular area and 
angiogenic gene expression. Grey scale assessment of synovial thickness also correlated with 
cellular markers of synovial inflammation and pro-inflammatory cytokines. Therefore, the 
assessment of synovial joint inflammation in early arthritis, by ultrasound, has considerable 
validity. How these relationships alter and potentially evolve following therapeutic 
intervention can only be dissected further in a prospective fashion. 
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